Asymptomatic valvular disease: Who benefits from surgery?

Current Cardiology Reports

Volumn 7, Issue 2, 2005, Pages 87-93

  Botkin, Naomi F ^b   Seth, Paula S ^b   Aurigemma, Gerard P ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; VASODILATOR AGENT;

AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ATHEROSCLEROSIS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE SEVERITY; EXERCISE TEST; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART VALVE REPLACEMENT; HEART VALVE SURGERY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; MEDICAL DECISION MAKING; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NON INVASIVE MEASUREMENT; PHYSICAL EXAMINATION; REVIEW; SUDDEN DEATH; SURGICAL RISK; SYMPTOM; TRANSLUMINAL VALVULOPLASTY; VALVULAR HEART DISEASE; ADULT; AGE; AGED; ALGORITHM; AORTA VALVE STENOSIS; CHRONIC DISEASE; COMPARATIVE STUDY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MALE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TIME;

ADULT; AGE FACTORS; AGED; ALGORITHMS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CHRONIC DISEASE; CLINICAL TRIALS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20644445222     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-005-0018-2     Document Type: Review

References (43)

1. Stewart BF, Siscovick D, Lind BK, et al.: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630-634.
2. US Census Bureau web site: http://factfinder.census.gov/home/saff/main.html
3. Otto CM, Kuusisto J, Reichenbach DD, et al.: Characterization of the early lesion of "degenerative" valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994, 90:844-853.
4. Horstkotte D, Loogen F: The natural history of aortic stenosis. Eur Heart J 1988, 9:E57-E64.
5. Piper C, Bergemann R, Schulte HD, et al.: Can progression of valvar aortic stenosis be predicted accurately? Ann Thor Surg 2003, 76:676-680.
6. Bonow RO, Carabello B, de Leon AC Jr, et al.: Guidelines for the management of patients with valvular heart disease: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 1998, 98:1949-1984.
7. Pellikka PA, Nishimura RA, Bailey KR, et al.: The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990, 15:1012-1017.
8. Otto CM, Burwash IG, Legget ME, et al.: Prospective study of asymptomatic valvular aortic stenosis. Circulation 1997, 95:2262-2270.
9. Sharma M, Aurigemma GP, Meyer TE, et al.: Recurrent syncope after successful aortic valve replacement. Am Heart J 1996, 132:194-197.
10. Gerber IL, Stewart RA, Legget ME, et al.: Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003, 107:1884-1890.
11. Kelly TA, Rothbart RM, Cooper CM, et al.: Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol 1988, 79:744-755.
12. Amato MCM, Moffa PJ, Werner KE, et al.: Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001, 86:381-386.
13. Connolly HM, Oh JK, Orszutak TA, et al.: Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Circulation 1997, 85:2395-2400.
14. Smith N, McAnulty JH, Rahimtoola SH: Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978, 58:255-264.
15. Monin JL, Monchi M, Gest V, et al.: Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients. J Am Coll Cardiol 2001, 37:2101-2107.
16. Tarantini G, Buja P, Scognamiglio R, et al.: Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery. Eur J Cardiothorac Surg 2003, 24:879-885.
17. STS US Cardiac Surgery Database for 1997. http://www.cts-net.org/doc/3031.
18. Butchart EG, Li H, Payne N, et al.: Twenty years' experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001, 121:1090-1100.
19. Akins CW: Mechanical cardiac valvular prostheses. Ann Thorac Surg 1991, 52:161-172.
20. Hammermeister KE, Sethi GK, Henderson WG, et al.: A comparison of outcomes in men 11 years after heart valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 1993, 328:1289-1296.
21. Orsinelli DA, Aurigemma GP, Battista S, et al.: Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993, 22:1679-1683.
22. Aurigemma G, Battista S, Orsinelli D, et al.: Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality [see comment]. Circulation 1992, 86:926-36.
23. Phillips BJ, Karavas AN, Aranki SF, et al.: Management of mild aortic stenosis during coronary artery bypass surgery: an update, 1992-2001. J Card Surg 2003, 18:507-511.
24. Diethrich EB: The treatment of aortic stenosis: is valvuloplasty ever an alternative to surgery? J Interv Cardiol 1993, 6:7-13.
25. Shavelle DM, Takasu J, Budoff MJ, et al,: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002, 359:1125-1126.
26. Novaro G, Tiong IY, Pearce BL, et al.: Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001, 104:2205-2209.
27. Bellamy MF, Pellikka PA, Klarich KW, et al.: Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002, 40:1723-1730.
28. O'Brien KD, Shavelle DM, Caulfield MT, et al.: Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002, 106:2224-2230.
29. Bonow RO, Lakatos E, Maron BJ, et al.: Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991, 84:1625-1635.
30. Ishii K, Hirota Y, Suwa M, et al.: Natural history and left ventricular response in chronic aortic regurgitation. Am J Cardiol 1996, 78:357-361.
31. Chaliki HP, Mohty D, Avierinos JF, et al.: Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002, 106:2687-2693.
32. Klodas E, Enriquez-Sarano M, Tajik AJ, et al.: Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction. J Am Coll Cardiol 1996, 27:670-677.
33. Grayburn PA: Vasodilator therapy for chronic aortic and mitral regurgitation. Am J Med Sci 2000, 320:202-208.
34. Scognamiglio R, Fasoli G, Ponchia A, et al.: Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990, 16:424-429.
35. Scognamiglio R, Rahimtoola SH, Fasoli G, et al.: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994, 331:689-694.
36. Mudge CH Jr.: Asymptomatic mitral regurgitation: when to operate? J Card Surg 1994, 9(Suppl):248-251.
37. Carabello BA: Progress in mitral and aortic regurgitation. Progr Cardiovasc Dis 2001, 43:457-475.
38. Goldfine H, Aurigemma GP, Zile MR, et al.: Left ventricular length-force-shortening relations before and after surgical correction of chronic mitral regurgitation. J Am Coll Cardiol 1998, 31:180-185.
39. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al.: Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994, 90:830-837.
40. Wisenbaugh T, Skudicky D, Sareli P: Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1194, 89:191-197.
41. Reed D, Abbott RD, Smucker ML, et al.: Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation: importance of left atrial size. Circulation 1991, 84:23-34.
42. The Society of Thoracic Surgeons Database. http://www.sts.org
43. Smolens IA, Pagani FD, Deeb GM, et al.: Prophylactic mitral reconstruction for mitral regurgitation. Ann Thor Surg 2001, 72:1210-1215.